Overview
CustoMed is a Singapore-based medical technology company founded in 2023 that develops 3D-printed patient-specific surgical instruments. The company designs customised tools tailored to individual patient anatomy to be used during surgical procedures.
The company addresses the need for improved precision in orthopedic surgery. Patient-specific instruments are designed to fit each individual's unique anatomical structure, with the stated aim of enhancing surgical accuracy, reducing operation times, and improving overall surgical outcomes.
Activities and products
CustoMed's product portfolio includes CustoMed OrthoPrint and CustoMed SpineAlign. Both are 3D-printed patient-specific instruments designed for use in orthopedic surgical procedures. The instruments are customised based on individual patient anatomy to support surgical precision during operations.
Stage and funding
CustoMed is at seed stage. The company raised $6 million in seed funding in 2023, its founding year. No further details regarding investors or subsequent funding rounds are currently verified.
Photograph: Ales Nesetril / Unsplash
Company details
- Legal name
- CustoMed
- Website
- www.customed.com
- Headquarters
- Singapore, Singapore
- Founded
- 2023
- Sector
- MedTech
- Funding stage
- Seed